StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

3-(5H-Dibenzo[a,d]cyclohepten-5-yliden)propyl(dimethyl)ammoniumchlorid

Cyclobenzaprine Hydrochloride

HCID 22576
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
6202-23-9
Standard-SMILES
CN(C)CCC=C1c2ccccc2C=Cc2ccccc21.Cl
InChIKey
VXEAYBOGHINOKW-UHFFFAOYSA-N
Summenformel
C20H22ClN
Durchschnittliche Molmasse
311,8 g/mol
Monoisotopische Masse
311,14407738

Überblick

Cyclobenzaprine hydrochloride is the hydrochloride salt of cyclobenzaprine. A centrally acting skeletal muscle relaxant, it is used in the symptomatic treatment of painful muscle spasm. It has a role as an antidepressant and a muscle relaxant. It contains a cyclobenzaprine. It derives from a hydride of a dibenzo[a,d][7]annulene.

Namen und Bezeichner

Bevorzugter Name
Cyclobenzaprine Hydrochloride
IUPAC
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)propan-1-amine;hydrochloride
Lokaler Name
3-(5H-Dibenzo[a,d]cyclohepten-5-yliden)propyl(dimethyl)ammoniumchlorid
Englischer Name
Cyclobenzaprine hydrochloride
Summenformel
C20H22ClN
Molmasse
311.85

Namen und Synonyme

Cyclobenzaprine hydrochloride6202-23-9Cyclobenzaprine HCLFlexerilFlexibanAmrixCycloflexClobenNovo-CycloprineTabradolTNX-102DTXSID2045105
Weitere Namen anzeigen
FlexibaLisserilCyclobezaprine HClMK130 hydrochlorideNortriptyline EP Impurity EAmitriptyline EP Impurity B
CYCLOBENZAPRINE HCI0VE05JYS2PNSC-78206NSC-169900NSC-17337910,11delta-Amitriptyline hydrochlorideCHEBI:3997DTXCID0025105

Datenbank-Bezeichner

CAS
6202-23-9
PubChem CID
22576
DTXSID
DTXSID2045105
ChEMBL
CHEMBL1200636
ChEBI
CHEBI:3997
UNII
0VE05JYS2P
EC Number

Eigenschaften

Berechnete Struktureigenschaften

Polarare Oberfläche (TPSA)
3,2 Ų
H-Brücken-Donoren
1
H-Brücken-Akzeptoren
1
Frei drehbare Bindungen
3
Schwere Atome
22
Formalladung
0
Komplexität
365

Experimentelle und physikochemische Eigenschaften

Human Drugs · 3 Einträge

Breast Feeding; Lactation; Milk, Human; Muscle Relaxants, Central

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physikochemische Eigenschaften

Schmelzpunkt
216 · 216-2180C
Flammpunkt
9 ℃ · 9℃
storage temp.
Inert atmosphere,Room Temperature
Wasserlöslichkeit
Completely soluble in water
Löslichkeit
15.59 mg/mL · ≥15.59 mg/mL in DMSO; ≥5.32 mg/mL in EtOH; ≥54.3 mg/mL in H2O
Aggregatzustand
Solid
Farbe
White to Almost white
Merck
14 · 14,2713
Major Application
pharmaceutical (small molecule)
InChI
1S/C20H21N.ClH/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20;/h3-6,8-14H,7,15H2,1-2H3;1H
InChIKey

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 1.8% (1 of 55) of reports.

Danger

H301 (89.1%): Toxic if swallowed [Danger Acute toxicity, oral]

P261, P264, P270, P271, P272, P280, P301+P316, P302+P352, P304+P340, P317, P321, P330, P333+P317, P362+P364, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 55 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information1-Propanamine, 3-(5H-dibenzoa,dcyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Other Safety InformationIMAP assessments - 1-Propanamine, 3-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-, hydrochloride: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (89.1%)

Toxikologische Informationen

Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Cyclobenzaprine hydrochloride

vLess-DILI-concern

5

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Chemie und Industrie

Pharmakologische Informationen

FDA Pharmacological Classification · 6 Einträge

CYCLOBENZAPRINE HCL

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

CYCLOBENZAPRINE HCL ER

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

CYCLOBENZAPRINE HYDROCHLORIDE

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

MeSH Pharmacological Classification · 3 Einträge

Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358)

A traditional grouping of drugs said to have a soothing or calming effect on mood, thought, or behavior. Included here are the ANTI-ANXIETY AGENTS (minor tranquilizers), ANTIMANIC AGENTS, and the ANTIPSYCHOTIC AGENTS (major tranquilizers). These drugs act by different mechanisms and are used for different therapeutic purposes.

Anwendungen · 2 Einträge

BeschreibungCyclobenzaprine is a skeletal muscle relaxant that also has sedative properties. It has been shown to antagonize muscarinic receptors (Kis = 25, 60, and 6 nM for M1, M2, and M3, respectively), serotonin 5-HT2 receptors (Kis = 56 and 330 nM for 5-HT2C and 5-HT2B, respectively), and histamine H1 receptor (IC50 = 20 nM).

Zugehörige Reaktionen

3
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 2061222
HRID 2061222als Edukt
Reaktionsgleichung von HRID 2236003
HRID 2236003als Edukt
Reaktionsgleichung von HRID 2374821
HRID 2374821als Edukt

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
228-264-4
VXEAYBOGHINOKW-UHFFFAOYSA-N
SMILES
Cl.CN(C)CC\C=C1\c2ccccc2C=Cc3ccccc13
CAS Datenbank
6202 · 6202-23-9(CAS DataBase Reference)

Sicherheitsdaten

wgk
3
ridadr
UN 2811 6.1/PG 3
hs_code
29214990
RTECS-Nr.
HP0875000
risk_code
20/21/22-39/23/24/25-23/24/25-11
Toxizität
LD50 in mice (mg/kg): 35 i.v., 250 orally (Metysova)
hazard_code
Xn,T,F
safety_code
36-45-36/37-16-7
hazard_class
6.1(b)
packing_group
III
Speicherklasse
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
Acute Tox. 3 OralAcute Tox. 4 DermalAcute Tox. 4 Inhalation

VerwendenCyclobenzaprine hydrochloride cam be used as muscle relaxant (skeletal).

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

Hydrogenchlorid3-Chlorpropyl(dimethyl)amin

Ergänzende Hinweise

DefinitionChEBI: The hydrochloride salt of cyclobenzaprine. A centrally acting skeletal muscle relaxant, it is used in the symptomatic treatment of painful muscle spasm.